-+ 0.00%
-+ 0.00%
-+ 0.00%

Brookline Capital Downgrades Lisata Therapeutics to Hold

Benzinga·01/21/2026 16:04:56
Listen to the news
Brookline Capital analyst Kemp Dolliver downgrades Lisata Therapeutics (NASDAQ:LSTA) from Buy to Hold.